Loading company…
Riskpilot
← Back to search
Sign in
Get full access
JW Pharma ApS
APS
Dissolved
CVR 39330563
Weidekampsgade 33, 1. tv
Retail sale of other food · NACE 4727
Est. 2018
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -6K
+26% vs 2023
EBITDA margin
100.0%
-26% vs 2023
Equity ratio
-50.3%
Financial strength
Net profit 2024
DKK -6K
-26% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -6K
+26%
EBITDA
DKK -6K
-26%
Net profit
DKK -6K
-26%
Total assets
DKK 292K
-2%
Equity
DKK -147K
-4%
Employees
—
—
Company information
Legal name
JW Pharma ApS
CVR number
39330563
Legal form
Anpartsselskab
NACE code
4727 · Retail sale of other food
Founded
12. februar 2018
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og bestyrelsesformand.
Contact
Address
Weidekampsgade 33, 1. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of other food
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2018
2019
2020
2021
2022
2023
2024
Revenue
-85
-125
70
-33
-8
-5
-6
Staff expenses
-0
-0
-0
-0
-0
-0
-0
EBITDA
-85
-125
70
-33
-8
-5
-6
Depreciation & amort.
-0
-0
-0
-0
-0
-0
-0
EBIT
-85
-125
70
-33
-8
-5
-6
Net financials
-2
-0
-0
-2
-2
0
0
Profit before tax
-87
-125
69
-35
-9
-5
-6
Tax
-0
-0
-0
-0
-0
-0
-0
Net profit
-87
-125
69
-35
-9
-5
-6
Balance sheet
DKK thousands
Item
2018
2019
2020
2021
2022
2023
2024
Total assets
583
452
347
312
303
298
292
Equity
-37
-162
-92
-127
-137
-141
-147
Long-term debt
615
594
436
436
436
436
436
Short-term debt
5
20
3
3
3
3
3
Total debt
620
614
439
439
439
439
439
Financial ratios
5-year trend
EBITDA margin
-585700.0%
This company
15.8%
Market median
-3707062% vs market
2018
2024
Equity ratio
-50.3%
This company
38.2%
Market median
-232% vs market
2018
2024
Return on equity
-585700.0%
This company
18.4%
Market median
-3183252% vs market
2018
2024
Net profit margin
-585700.0%
This company
8.1%
Market median
-7230964% vs market
2018
2024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
2018
2024
Debt / equity
2.99×
This company
0.62×
Market median
-382% vs market
2018
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-02-12 – 2018-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Yan Wong
Individual
66.7%
66.7%
2018
Jie Chen
Individual
10.0%
10.0%
2018
Jun Chen
Individual
10.0%
10.0%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of JW Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies